| No images? Click here  Friday, 28 June 2024 | Issue 261  Photo credit: WHO  Tuesday, 02 July The first-ever global estimates of economic costs caused by genital herpes infections and their related complications The new research, which shows the major economic toll from herpes infections globally, will be published in BMC Global and Public Health on 02 July. Authored by experts from WHO, the University of Utah and various other academic institutions, the first-ever global estimates of economic costs caused by genital herpes infections and their related complications show that every year, these conditions lead to billions of dollars in healthcare expenditures and productivity losses. The paper details associated economic cost estimates for genital herpes globally and by region, and calls for greater investment in the prevention of herpes transmission, including concerted efforts to develop effective vaccines against this common virus. For embargoed access to the detailed report, and interview requests, contact mediainquiries@who.int (embargo lifts at 00:01 CEST/Geneva time on 2 July). Also see: Herpes simplex virus (factsheet) and Let’s Talk Herpes (video explainer)  Tuesday, 02 July Tobacco Clinical Treatment Guidelines The first WHO clinical treatment guidelines, focused on helping the 750 million tobacco users who want to quit all forms of tobacco, offer a comprehensive set of tobacco cessation interventions, including behavioural support delivered by healthcare providers, digital cessation interventions and pharmacological treatments. Recommendations are relevant for all adults seeking to quit various tobacco products, including cigarettes, waterpipes, smokeless tobacco products, cigars, roll-your-own tobacco, and heated tobacco products (HTPs). The guidelines address system-level interventions and policies, such as training healthcare providers and covering the cost of tobacco cessation interventions to enhance effective implementation and provide technical guidance to countries to standardize tobacco cessation interventions and encourage the use of essential medicines for tobacco cessation. Embargoed materials are available on request to levind@who.int with a copy to mediainquiries@who.int (embargo lifts at 09:00 CEST/Geneva time on 2 July).  Tuesday, 02 July Webinar on the new WHO estimates of physical inactivity in adults 14:00 – 15:30 CEST Being active is good for health. In this webinar, the WHO Department of Health Promotion, Physical Activity unit will discuss the new global comparable estimates of physical inactivity and will share key results and discuss implications for policy and practice. For the first time, the results also include a forecast of levels of inactivity in 2030 to assess if the world is on track to meet the global target of 15% relative reduction as set out in the Global Action Plan on Physical Activity. Visit this page for further information and registration. Interpretation in Spanish and French will be provided.  Wednesday, 03 July New report on the development of “therapeutic” vaccines to treat human papillomavirus Innovative vaccines could potentially treat dangerous human papillomavirus (HPV) infections in adults and therefore reduce the risk of cervical cancer. With over 20 therapeutic HPV vaccine candidates currently in development, a new report, WHO preferred product characteristics for therapeutic HPV vaccines, calls on developers to ensure they are designed to be used not only in wealthier contexts but also low and middle-income countries, where more than 90% of cervical cancer-related deaths occur. HPV infections are the leading cause of cervical cancer. Alongside wider access to screening and treatment, a therapeutic vaccine could provide a useful option for adult women who did not receive preventive vaccination and who have already been exposed to the virus. Embargoed materials are available on request to mediainquiries@who.int (embargo lifts at 01:01 CEST/Geneva time on 3 July). Also see: Human papillomavirus and cancer (factsheet) and Cervical cancer elimination initiative  WHO events here Sign up for our newsletters here Check out the WHO series, Science in 5 Access WHO photos available for media use here  WHO media contacts:  You are receiving this NO-REPLY email because you are included on a WHO mail list. |
Friday, June 28, 2024
WHO | Week Ahead for media - 28 June 2024
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment